New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
08:11 EDTINFIInfinity Pharmaceuticals sees 2013 net loss $115M-$125M
Consensus for FY13 EPS is ($3.04). The company said it entered 2013 with approximately $327M in cash and investments. Infinity expects operating expenses for 2013 to range from $115M-$125M, net loss for 2013 to range from $115M-$125M and expects to end 2013 with a year-end cash and investments balance ranging from $210M-$220M. Based on its current operating plan and exclusive of any business development activities, Infinity’s financial foundation provides a cash runway into 2015, the company said.
News For INFI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
08:03 EDTINFIInfinity Pharmaceuticals reports preclinical data for duvelisib
Subscribe for More Information
07:59 EDTINFIInfinity Pharmaceuticals participates in a conference call with JPMorgan
Conference call with CEO Perkins will be held on May 26 at 10 am hosted by JPMorgan.
May 18, 2015
07:22 EDTINFIUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link
May 13, 2015
17:25 EDTINFIInfinity Pharmaceuticals to present new data for duvelisib at ASCO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use